Besibac ophthalmic suspension is indicated for the treatment of bacterial
conjunctivitis caused by susceptible isolates of the following bacteria:
Corynebacterium pseudodiphtheriticum*
Corynebacterium striatum*
Haemophilus influenzae
Moraxella lacunata*
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus hominis*
Staphylococcus lugdunensis*
Streptococcus mitis group
Streptococcus oralis
Streptococcus pneumoniae
Streptococcus salivarius*

*Efficacy for this organism was studied in fewer than 10 infections.

Dosage & Administration

Instill one drop in the affected eye(s) 3 times a day for 7 days.


Besifloxacin for topical ophthalmic use only, and should not be injected subconjunctivally, nor should it be introduced directly into the anterior chamber of the eye.


Use in Specific Populations
Pregnancy Category C.
Nursing Mothers:
Besifloxacin has not been measured in human milk, although it can be presumed to be excreted in human milk. Caution should be exercised when Besifloxacin administered to a nursing mother.
Pediatric Use:
The safety and effectiveness of Besifloxacin in infants below one year of age have not been established. The efficacy of Besifloxacin in treating bacterial conjunctivitis in pediatric patients one year or older has been demonstrated in controlled clinical trials.
Geriatric Use:
No overall differences in safety and effectiveness have been observed between elderly and younger patients.

Product Details

Related Products

Moxibac Eye Drops

Moxifloxacin 0.5%

Levobac TS Eye Drops

Levofloxacin 1.5%

Lomebac Eye Drops

Lomefloxacin 0.3%

Tobrabac Eye Drops

Tobramycin 0.3%